The performance of companies tied to the drug's history presents a intricate investment picture . While the initial boom generated substantial returns , generic alternatives have significantly eroded https://pukkabookmarks.com/story21685576/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-risky-opportunity